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Abstract 
Background and Aim: Helicobacter pylori is not only identified as a leading cause of chronic active gastritis 
and peptic ulcer disease in humans, but also it is considered as a risk factor for the development of gastric 
adenocarcinoma and MALT lymphoma. This study aims to predict specific epitopes for the utility of designing 
peptide vaccine against H. pylori infection by targeting invasive, virulent and membrane associated proteins 
CagA. Materials and Methods: In the present study, various immunoinformatics approaches have been 
applied to design a potential epitope-based vaccine against H. pylori infection. For prediction of linear epitopes, 
the sequence of CagA was submitted to ABCpred, BCPREDS, Bcepred, Bepipred and Ellipro servers. 
DiscoTope 2.0 and B-pred servers were also used for the prediction of conformational epitopes. In addition, 
prediction of T-cell epitopes was carried out by CTLPred. Results: The obtained results demonstrated 277 
conformational B-Cell epitopes in addition to predicted high score linear B and T cell epitopes in CagA 
protein. Conclusion: These predicted epitopes might be used to design a vaccine against H. pylori and thus, 
could be validated in model hosts to verify their efficacy as vaccine. 
Keywords: CagA; Helicobacter pylori; B cell Epitope; T cell Epitope; In silico. 
 
*Corresponding Author: Sakineh Poorhosein Fookolaee; Email: a52_amin@yahoo.com  
Please cite this article as: Akbarian Rokni M, Talebishelimaki S, Poorhosein Fookolaee S, Saadati Rad MT, Owrang M. Applying 




     Helicobacter pylori is a microaerophilic spiral-
shaped lophotrichous and gram-negative bacterium 
that colonizes in the gastric lumen of primates, 
including humans [1]. H. pylori was identified as the 
cause of chronic active gastritis and peptic ulcer 
disease in humans and is considered to be a risk 
factor for the development of gastric adenocarcinoma 
and mucosa-associated lymphoid tissue (MALT) 
lymphoma [2]. Strains of H. pylori are grouped into 
two broad families tentatively named type I and type 
II, which are based on whether they express or not 
the vacuolating cytotoxin (VacA) and the CagA 
antigen (cytotoxin-associated gene A) [3]. An 
increasing body of evidence has shown that patients 
with duodenitis, duodenal ulcers, and gastric tumors 
are most often infected by type I strains, which 
suggests that CagA and the co-expressed cytotoxin 
play a role in its pathogenicity [4]. Identification of the 
common immunogenic proteins of H. pylori may be a 
major step toward the development of purer, better-
defined, and probably more-efficient vaccines. Such 
vaccines would confer cross-protection against a wide 
range of pathogenic H. pylori strains [5]. H. pylori 
vaccines development has been initiated from 2011 to 
predict novel T-cell epitopes. However, to the best of 
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our knowledge, there are no large pharmaceutical or 
biotechnology companies that have a current H. 
pylori vaccine development program. Therefore, the 
development of most H. pylori vaccines is currently 
at very early stage phases (Phase I or preclinical). For 
example, EpiVax, Helicovaxor®, and Lp220 are 
current vaccine candidates that are in preclinical 
phase [6]. These vaccines are composed of purified 
or recombinant components of H. pylori antigens 
with an adjuvant.   
     Current evidence indicates that CagA can be a 
good candidate for developing a new generation of 
vaccines that induce broad protection against H. 
pylori [7]. Active immunotherapy with peptide 
vaccines, which are designed to be chimeric with 
multi-epitopes of B cells and T helper cells, can 
induce generation of an adaptive immune response. 
Several experimental techniques are currently 
available for selection of suitable B and T cell 
epitopes [8]. The experimental approaches applied 
for detecting immunogenic regions are often 
laborious and resource-intensive. Computational 
techniques are fast, scalable, and cost-effective for B 
and T cell epitopes prediction, for focusing 
experimental investigations and for better 
understanding of antigen-antibody interactions [9, 
10]. B cell epitopes can be classified into two types: 
linear (continuous) and conformational 
(discontinuous). While linear epitopes comprise 
residues that are continuous in the sequence, 
conformational epitopes are composed of amino 
acids that are not neighboring in primary sequence 
and are brought into close proximity in the folded 
protein structure [11]. Moreover, sequence- and 
structure-based methods investigating the binding 
affinity of peptides to MHC I and MHC II molecules 
and other parameters may aid in the search for new 
antigens in order to support vaccine development 
[12]. The present research was conducted to predict 
new B and T cell epitopes for the CagA of H. pylori.  
Methods 
Retrieval of protein sequences. All sequences of 
CagA were retrieved from UniProt 
(https://www.uniprot.org) in FASTA format. 
Linear B cell epitopes prediction for CagA. For 
prediction of linear epitopes, CagA sequence was 
submitted to ABCpred, BCPREDS, Bcepred, Bepipred 
and Ellipro servers (13, 14). The hidden Markov 
model, Thornton’s method, Support Vector Machine 
classifiers, Recurrent Neural Network and physico-
chemical properties of amino acids were applied to 
predict the linear B cell epitopes. Only, the linear 
peptides which were predicted frequently by 3 or more 
servers were selected.  
Conformational B cell epitope prediction for CagA. 
DiscoTope 2.0 and B-pred servers were used for the 
prediction of conformational epitopes from the entire 
PDB structure of CagA that obtained from the 
homology modeling method (15). More recently, the 
sensitivity and specificity of DiscoTope 2.0 server for 
the prediction of vaccine against H. pylori were 0.47 
and 0.75, respectively (16). The DiscoTope method 
incorporates a new spatial neighborhood description 
and a half-sphere exposure as a surface measure based 
on the protein structure and epitope propensity scores 
and predicts residues that can be involved in B-cell 
epitopes. B-pred is a web-based platform for scoring 
and predicting B-cell epitopes based on  the structures  
of the potential immunological proteins. The method 
scores the peptides set of a protein based on the 
average solvent exposure, by a filter on filtering the 
average local model quality for each peptide. 
T cell epitope prediction for CagA. Prediction of T-
cell epitopes was carried out by CTLPred at 
http://www.imtech.res.in/raghava/ctlpred/. This server 
provides a direct method for the prediction of 
cytotoxic T lymphocyte (CTL) epitopes crucially 
based on Quantitative Matrix (QM), Support Vector 
Machine (SVM), and Artificial Neural Network 
(ANN) in subunit vaccine design [17]. 
MHC class I and II epitope prediction. Prediction of 
the promiscuous MHC class-I binding peptides was 
carried out by using of ProPred-I at 
http://www.imtech.res.in/raghava/propred1/. Also, this 
online server predicts MHC-I binding peptides for 47 
various alleles [18]. Prediction of binding peptides to 
class II MHC molecules was performed by means of 
RANKPEP online server [19]. 
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Results 
     The predicted linear B cell epitopes of the Cag A 
are shown in Table 1. The predicted B cell epitopes 
were ranked according to their score obtained by 
trained recurrent neural network. Higher score of the 
peptide means the higher probability to be as epitope. 
As listed in the table, peptides were predicted by 
different servers used in the current study. The 
peptide “NETIDQTRTPDQTQSQ” had highest score 
compared to the other epitopes. These peptides reside 
in 3-968 regions of the Cag A. 
 
Table 1. Predicted B cell epitopes according to their score 
obtained by trained recurrent neural network. 
Rank Sequence Start position Score 
1 NETIDQTRTPDQTQSQ 3 0.96 
2 QKPIVDKNDRDNRQAF 48 0.94 
2 SQTAFDPQQFINNLQV 17 0.94 
3 GGVGQAAGFPLKRHDK 940 0.93 
3 DALGNDRIAFVSKKDT 442 0.93 
4 QPDIATTTTDIQGLPP 242 0.92 
4 ENIIQPPIPDDKEKAE 148 0.92 
5 EAEKNGGPTGGDWLDI 200 0.91 
6 GKKADKALDREKNVTL 479 0.90 
7 GDLSYTLKDYGKKADK 469 0.89 
7 AGNGGFGDKHDWNATV 325 0.89 
8 DGISQLREEYSNKAIK 64 0.88 
8 SGLVIAGGEKGINNPS 362 0.88 
8 DVEGVADIDPNYKFNQ 281 0.88 
9 PEPIYATIDDLGGPFP 968 0.87 
9 QEEIRNKVDFMEFLAQ 395 0.87 
 
     Discotope and B-pred predicted 277 B-Cell 
epitope residues out of 656 total residues 
corresponding to conformational epitopes, 
approximately located in the region of linear B cell 
epitopes (Table 2). Further analysis for solvent 
accessible areas and relative solvent accessibility of 
all the residues on the PDB structures using Naccess 
program and NetSurfP server defined that predicted 
conformational B cell epitopes had higher solvent 
accessible and their residues were exposed on the 
surface (Fig 1). 
 
 
Fig 1. 3D structure of high score predicted discontinuous B cell 
epitopes. Predicted conformational B cell epitopes has higher solvent 
accessible and their residues were exposed on the surface. 
     Analysis using a combined algorithm integrating 
MHC epitope binding and T cell epitopes generated 3 
T cell epitopes from Cag A of H. pylori that interacted 
with different possible MHC I alleles with the IC50 
value <100 nM. These processed peptides were then 
analyzed by SMM based IEDB MHC I prediction tool. 
A good epitope should also interact with as many as 
MHC alleles. Thus, among the total peptides, only 
those peptides which interacted with minimum four 
MHC class I alleles as well as were found to be the 
core sequences of 15mer MHC class II alleles, were 
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P:I736, P:N737, P:P738, P:E739, P:W740, P:I741, P:S742, P:K743, P:V744, P:E745, P:N746, P:L747, P:N748, 
P:A749, P:A750, P:L751, P:N752, P:E753, P:F754, P:K755, P:N756, P:F762, P:S763, P:K764, P:V765, P:T766, 
P:Q767, P:A768, P:K769, P:S770, P:D771, P:L772, P:E773, P:N774, P:S775, P:V776, P:K777, P:D778, 
P:V779, P:I780, P:I781, P:N782, P:Q783, P:K784, P:V785, P:T786, P:D787, P:K788, P:V789, P:D790, P:N791, 
P:L792, P:N793, P:Q794, P:A795, P:V796, P:S797, P:V798, P:A799, P:K800, P:A801, P:M802, P:G803, 
P:D804, P:F805, P:S806, P:R807, P:V808, P:E809, P:Q810, P:V811, P:L812, P:A813, P:D814, P:L815, 
P:K816, P:N817, P:F818, P:S819, P:K820, P:E821, P:Q822 
82 0.803 
2 
P:P546, P:D547, P:L548, P:N549, P:N550, P:L551, P:A552, P:I553, P:T554, P:S555, P:F556, P:V557, P:R558, 
P:R559, P:N560, P:L561, P:E562, P:N563, P:K564, P:L565, P:T566, P:A567, P:K568, P:G569, P:L570, P:S571, 
P:L572, P:Q573, P:E574, P:A575, P:N576, P:K577, P:L578, P:I579, P:K580, P:D581, P:L583, P:S584, P:R626, 
P:H628, P:L629, P:E630, P:K631, P:E632, P:V633, P:E634, P:K635, P:K636, P:L637, P:E638, P:S639, P:K640, 
P:S641, P:N645, P:K646, P:M647, P:E648, P:A649, P:K650, P:A651, P:Q652, P:A653, P:N654, P:S655, 
P:Q656, P:K657, P:D658, P:E659, P:I660, P:F661, P:A662, P:L663, P:I664 
73 0.784 
3 
P:L69, P:E71, P:E72, P:Y73, P:S74, P:N75, P:K76, P:A77, P:I78, P:N80, P:P81, P:T82, P:K83, P:K84, P:N85, 
P:Q86, P:Y87, P:F88, P:S89, P:D90, P:F91, P:I92, P:D93, P:K94, P:S95, P:N96, P:D97, P:L98, P:I99, P:N100, 
P:K101, P:D102, P:N103, P:L104, P:I105, P:D106, P:V107, P:E108, P:S109, P:S110, P:T111, P:K112, P:S113, 
P:F114, P:Q115, P:K116, P:F117, P:G118, P:D119, P:Q120, P:R121, P:Y122, P:Q123, P:I124, P:K186, P:F187, 
P:M188, P:G189, P:V190, P:F191, P:D192, P:E193, P:S194, P:L195, P:K196, P:E197, P:R198, P:Q199, 
P:E200, P:A201, P:E202, P:K203, P:N204, P:G205, P:G206, P:P207, P:T208, P:G209, P:G210, P:D211, 
P:W212, P:L213, P:D214, P:I215, P:L217, P:S218 
86 0.728 
4 P:L699, P:K700, P:F702, P:S703, P:K704, P:S705, P:F706, P:D707, P:E708, P:F709, P:K710 11 0.718 
5 
P:E148, P:N149, P:I150, P:I151, P:Q152, P:P153, P:P154, P:I155, P:P156, P:D157, P:D158, P:K159, P:E160, 
P:K161, P:E163 
15 0.699 
6 P:E318, P:K319, P:G341, P:Y342, P:K343, P:N349, P:V350 7 0.675 
7 
P:A303, P:L304, P:S305, P:S306, P:V307, P:L308, P:G310, P:S311, P:H312, P:N313, P:G314, P:I315, P:V320, 
P:S321, P:L322, P:Y324, P:G326, P:N327, P:G328, P:G329, P:F330, P:H334 
22 0.621 
8 P:E588, P:K617, P:D618, P:E620, P:K621, P:S622, P:R624, P:K625 8 0.602 
9 P:Y508, P:S509, P:F537 3 0.584 
10 P:K455, P:D456, P:T457, P:K458, P:H459 5 0.568 
11 P:D45, P:P46, P:D47, P:Q48 4 0.557 
12 P:N608, P:D610, P:K613 3 0.504 
 
Table 3. Predicted T cell epitopes according to their score using different server 
Peptide Rank Start Position Sequence Score (ANN/SVM) 
1 22 DPQQFINNL 0.97/1.2919966 
2 967 SPEPIYATI 0.94/1.2222893 
3 436 DSKAYLDAL 0.96/1.0907681 
 
Discussion 
     To find out remedial alternatives, the identification of 
new bio-targets is, therefore, highly anticipated. 
Understanding of molecules involved in pathogenesis 
has the potential to yield new and exciting strategies for 
therapeutic intervention [20]. The CagA protein antigen 
of H. pylori is arguably the most well-studied virulence 
factor of H. pylori that facilitates its colonization into the 
intestinal tract [21]. In this study, we made an attempt to 
predict novel T and B cell epitopes which could be 
tested for their efficacy in eliciting immunity through 
humoral and cell mediated immune responses. However, 
the activation of cytotoxic T-cells requires recognition of 
specific peptides bound to MHC class I molecules and 
while sequences from pathogens provide a huge amount 
of potential vaccine candidates, it is estimated that only 
one in 100 to 200 peptides actually binds to a particular 
MHC. Therefore, a good computational prediction 
method can significantly reduce the number of peptides 
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that have to be synthesized and tested. With the advent 
of computers and informatics, new approaches have 
been devised that facilitate immunoinformatics which 
targets the use of mathematical and computational 
approaches to predict T-cell and B-cell immune epitopes 
[22]. Identification of B-cell epitopes is rather important 
to immunodetection and immunotherapeutic applications 
since an epitope as the minimal immune unit is strong 
enough to elicit a potent humoral immune response with 
no harmful side effects to human body [11]. In this 
study, linear B-cell epitopes were chosen with two 
different algorithms, BepiPred and ABCpred. Only 
overlapping peptides which were chosen by both 
algorithms, as well as satisfied the scores of VaxiJen and 
passed transmembrane topology were selected as 
potential B-cell epitopes and subjected to further 
analysis using the parameters of surface accessibility, 
hydrophilicity, flexibility, and beta-turn. By cross-
referencing of all the data, we predicted that the peptide 
sequences were capable of inducing the desired immune 
response as B cell epitope. For T cell epitope prediction, 
plenty of algorithms are freely available, and in this 
study, we employed IEDB analysis tool which is 
possibly the most wide-ranging database offering several 
B cell and T cell epitope-related analysis and prediction 
tools, as well as provides both intrinsic biochemical and 
extrinsic context dependent information about them. 
Initial analysis of the data showed that most of the 
predicted epitopes interacted with the highest numbers 
of MHC class I alleles, were the core peptides of a 
maximum number of MHC class II binding predictions 
and also demonstrated large world population coverage 
[16]. Further analysis found out the highest population 
coverage, interacted with 6-9 MHC class I alleles and 
also were found to be overlapping with a good number 
of 15mer peptides of MHC class II alleles. All epitopes 
showed 100 % conservancy among the majority of 
strains. In summary, in this study, we made an attempt 
to predict novel B and T cell epitope against Cag A of H. 
pylori which could be tested for their efficacy in eliciting 
immunity through humoral and cell mediated immune 
responses. The results of our study provide 
computational data for the identification and screening 
of epitopes, and may be used for the development of 
epitope vaccines that have an enhanced safety and 
efficacy. Our findings are based on sequence analysis 
and computational predictions. However, to prove the 
effectiveness of mounting an immune response, both in 
vitro and in vivo studies are required along with this in 
silico study. 
Conclusion 
     In this research, we used immunoinformatics 
methods to predict appropriate vaccine against H. pylori. 
Our data revealed 277 conformational B-Cell epitopes in 
addition to predicted high score linear B and T cell 
epitopes in Cag A protein. All sequences were joined to 
each other by proper linkers. Epitopes were evaluated as 
nonallergenic, antigenic, soluble, with safety and 
efficacy. These predicted epitopes might be used to 
design a vaccine against H. pylori and thus, could be 
validated in model hosts to verify their efficacy as 
vaccine. 
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